Mark A Goldsmith Revolution Medicines, Inc. (RVMD) insider trading activity

Mark A Goldsmith is of Revolution Medicines, Inc.. Currently has a direct ownership of 452,879 shares of RVMD, which is worth approximately $17.4 Million. The most recent transaction as insider was on Apr 10, 2024, when has been sold 7,500 shares (Common Stock) at a price of $35.48 per share, resulting in proceeds of $266,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 453K

2.85% 3M change

27.26% 12M change

Total Value Held $17.4 Million

MARK A GOLDSMITH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 10 2024	SELL Open market or private sale	$266,100 $35.48 p/Share	7,500 Reduced 1.63%	452,879 Common Stock
Mar 18 2024	SELL Open market or private sale	$182,785 $31.58 p/Share	5,788 Reduced 1.24%	460,379 Common Stock
Mar 01 2024	SELL Grant, award, or other acquisition	-	90,000 Reduced 16.18%	466,167 Common Stock
Dec 18 2023	SELL Open market or private sale	$211,473 $25.9 p/Share	8,165 Reduced 2.12%	376,167 Common Stock
Oct 24 2023	BUY Exercise of conversion of derivative security	$17,150 $0.49 p/Share	35,000 Added 8.35%	384,332 Common Stock
Sep 18 2023	SELL Open market or private sale	$252,170 $31.31 p/Share	8,054 Reduced 2.25%	349,332 Common Stock
Sep 01 2023	SELL Open market or private sale	$1,051,500 $35.05 p/Share	30,000 Reduced 7.74%	357,386 Common Stock

Sep 01 2023	BUY Exercise of conversion of derivative security	$24,900 $0.83 p/Share	30,000 Added 7.19%	387,386 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	104,000 Added 22.61%	355,872 Common Stock
Feb 22 2023	BUY Exercise of conversion of derivative security	$22,050 $0.49 p/Share	45,000 Added 15.16%	251,872 Common Stock
Aug 11 2022	BUY Exercise of conversion of derivative security	$4,900 $0.49 p/Share	10,000 Added 4.61%	206,872 Common Stock
Aug 09 2022	BUY Exercise of conversion of derivative security	$5,065 $0.49 p/Share	10,336 Added 4.99%	196,872 Common Stock
Mar 17 2022	SELL Open market or private sale	$19,038 $18.61 p/Share	1,023 Reduced 0.55%	185,599 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	104,000 Added 35.79%	186,622 Common Stock
Dec 17 2021	SELL Open market or private sale	$38,348 $24.41 p/Share	1,571 Reduced 1.87%	82,622 Common Stock
Dec 06 2021	BUY Exercise of conversion of derivative security	$18,483 $0.49 p/Share	37,721 Added 30.94%	84,193 Common Stock
Sep 17 2021	SELL Open market or private sale	$45,961 $30.02 p/Share	1,531 Reduced 3.19%	46,472 Common Stock
Jun 17 2021	SELL Open market or private sale	$50,223 $33.82 p/Share	1,485 Reduced 3.0%	48,003 Common Stock
Mar 04 2021	BUY Grant, award, or other acquisition	-	48,000 Added 49.62%	48,744 Common Stock
Mar 01 2021	SELL Open market or private sale	$230,000 $46.0 p/Share	5,000 Reduced 87.05%	744 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$5,600 $1.12 p/Share	5,000 Added 46.54%	5,744 Common Stock
Feb 05 2021	SELL Open market or private sale	$825,000 $55.0 p/Share	15,000 Reduced 95.27%	744 Common Stock
Feb 05 2021	BUY Exercise of conversion of derivative security	$16,800 $1.12 p/Share	15,000 Added 48.79%	15,744 Common Stock
Feb 02 2021	SELL Open market or private sale	$228,800 $45.76 p/Share	5,000 Reduced 87.05%	744 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$5,600 $1.12 p/Share	5,000 Added 46.54%	5,744 Common Stock

Also insider at

CNST

CONSTELLATION PHARMACEUTICALS INC Healthcare

MAG

Mark A Goldsmith

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVMD shares.

Notify only if

Value

Insider Trading

Get notified when an Revolution Medicines, Inc. insider buys or sells RVMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to Revolution Medicines, Inc.

Track Activities on RVMD

Account